Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study

201891 citationsJournal Article

Authors

Both ruxolitinib and tofacitinib could be considered effective and well-tolerated treatments for extensive AA.

Good health and well-being

Published in: Dermatology

Volume 235, Issue 2, pp. 130-136

Field-Weighted Citation Impact: 9.01